NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 878 filers reported holding NOVARTIS A G in Q2 2016. The put-call ratio across all filers is 1.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,969,000 | -4.0% | 88,262 | +0.3% | 1.22% | -7.7% |
| Q2 2016 | $7,262,000 | +6.4% | 88,012 | -6.6% | 1.33% | +4.1% |
| Q1 2016 | $6,824,000 | -7.9% | 94,210 | +9.3% | 1.28% | -8.5% |
| Q4 2015 | $7,413,000 | +2.9% | 86,160 | +17.6% | 1.39% | +13.4% |
| Q2 2015 | $7,205,000 | +2.5% | 73,270 | +2.8% | 1.23% | -4.1% |
| Q1 2015 | $7,026,000 | +6.4% | 71,250 | 0.0% | 1.28% | +7.6% |
| Q4 2014 | $6,602,000 | +7.2% | 71,250 | +8.9% | 1.19% | +2.2% |
| Q3 2014 | $6,156,000 | +59.0% | 65,400 | +53.0% | 1.16% | +70.9% |
| Q2 2014 | $3,871,000 | -3.6% | 42,750 | -9.5% | 0.68% | -9.1% |
| Q1 2014 | $4,017,000 | +50.3% | 47,250 | +42.1% | 0.75% | +46.3% |
| Q4 2013 | $2,673,000 | +2.8% | 33,250 | -1.9% | 0.51% | -1.5% |
| Q3 2013 | $2,601,000 | +11.8% | 33,900 | +3.0% | 0.52% | +6.1% |
| Q2 2013 | $2,326,000 | – | 32,900 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |